Peter Buser

Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents

Matthias Pfisterer, Hans‐Peter Brunner‐La Rocca, Peter Buser et al. · Journal of the American College of Cardiology · 2006 · 1.3K citations

Medicine, Cardiology, Pharmacotherapy +15

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)

Michele Brignole, Angelo Auricchio, Gonzalo Barón‐Esquivias et al. · EP Europace · 2013 · 1.1K citations · Full text

Medicine, Cardiology, Cardiovascular Pharmacotherapy +11

Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea

Christian Mueller, André Scholer, Kirsten Laule-Kilian et al. · New England Journal of Medicine · 2004 · 1K citations

Medicine, Cardiology, Internal Medicine +16

BNP-Guided vs Symptom-Guided Heart Failure Therapy

Matthias Pfisterer, Peter Buser, Hans Rickli et al. · JAMA · 2009 · 644 citations

Medicine, Cardiology, Internal Medicine +15

Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial

Raban Jeger, Ahmed Farah, Marc‐Alexander Ohlow et al. · The Lancet · 2018 · 455 citations

Medicine, Cardiology, Pharmacology +16